Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Entrada Therapeutics Clinical Trial Data Sparks Brutal Stock Selloff - Here's Why
Entrada's Duchenne drug shown to improve muscle function in early trial